|
Status |
Public on Jun 21, 2022 |
Title |
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia [mouse_RNA-seq] |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Detailed genomic and epigenomic analyses of MECOM (the MDS1 and EVI1 complex locus) have revealed that inversion or translocation of chromosome 3 at MECOM drive inv(3)/t(3;3) myeloid leukemias and revealed MECOM germline mutations in patients with MECOM-associated bone marrow failure syndromes. Here we identify a novel, previously unannotated oncogenic RNA-splicing derived isoform of EVI1 which is frequently present in inv(3)/t(3;3) AML and directly contributes to leukemic transformation. Expression of this EVI1 splice variant enhanced the self-renewal of hematopoietic stem cells and introduction of mutant SF3B1 in mice bearing the humanized inv(3)(q21;26) allele hastened leukemogenesis in vivo. These data provide a mechanistic basis for the frequent co-occurrence of SF3B1 mutations as well as new insights into the pathogenesis of myeloid leukemias harboring inv(3)/t(3;3).
|
|
|
Overall design |
1.0 x 10E6 total BM cells of Mx1-Cre control, Mx1-Cre inv(3), Mx1-Cre Sf3b1K700E/WT, and Mx1-Cre inv(3) Sf3b1K700E/WT CD45.2+ mice were mixed with 1.0 x 10E6 WT CD45.1+ support BM and transplanted via tail vein injection into lethally irradiated (two times 450 cGy) CD45.1+ recipient mice. Four weeks after BMT, the recipient mice received 20 mg/kg pIpC injection every other day for a total of 3 doses. Six months after pIpC injection, the recipient mice were sacrificed for sample preparation.
|
|
|
Contributor(s) |
Penson A, Nomura M, Inoue D, Abdel-Wahab O |
Citation(s) |
35709354 |
|
Submission date |
Dec 10, 2021 |
Last update date |
Jun 25, 2022 |
Contact name |
Masaki Nomura |
E-mail(s) |
[email protected]
|
Organization name |
Foundation for Biomedical Research and Innovation at Kobe
|
Street address |
6-3-7 Minatojima Minamimachi, Chuo Ward
|
City |
Kobe |
State/province |
Hyogo |
ZIP/Postal code |
650-0047 |
Country |
Japan |
|
|
Platforms (1) |
GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
Samples (12)
|
|
This SubSeries is part of SuperSeries: |
GSE190656 |
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia |
|
Relations |
BioProject |
PRJNA787924 |
SRA |
SRP350270 |